NewsJune 12, 2026How to profit from London’s most-shorted stockBrickmaker Ibstock currently carries the unenviable title, but perhaps unfairly
NewsJune 9, 2026Music stocks struggle – but can they turn the tables on AI?Universal Music and Warner Music’s shares have been hit hard, but not everyone is convinced AI is an existential threat
NewsJune 11, 2026AstraZeneca and Roche battle for a cancer breakthroughBillions of dollars are at stake as the pharma giants fight it out for the next winner in breast cancer treatment
PropertyJune 8, 2026The issues inside the foundations of the construction industryCompanies down the supply chain are confronting a host of issues as they face another downturn
NewsJune 9, 2026Music stocks struggle – but can they turn the tables on AI?Universal Music and Warner Music’s shares have been hit hard, but not everyone is convinced AI is an existential threat
IPOsJune 5, 2026The IC guide to buying newly listed sharesTrillion-dollar stocks are going public and ´óÏóÊÓÆµ want to take advantage. We explain everything you need to know
NewsJune 12, 2026SpaceX shares rise a quarter in record floatElon Musk’s rocket, internet and AI company raised $75bn in highest profile company float since tech boom began
NewsJune 12, 2026How to profit from London’s most-shorted stockBrickmaker Ibstock currently carries the unenviable title, but perhaps unfairly
NewsJune 11, 2026AstraZeneca and Roche battle for a cancer breakthroughBillions of dollars are at stake as the pharma giants fight it out for the next winner in breast cancer treatment
Results & Trading UpdatesJune 12, 2026RWS is helping build the AI models that threaten to replace itIts ‘TrainAI’ business is driving growth while its core service shrinks
Results & Trading UpdatesJune 11, 2026Safestore’s growth path remains secureBut higher debt costs are weighing on earnings growth
Results & Trading UpdatesJune 12, 2026Oracle’s AI expansion is testing its balance sheet The company has come under scrutiny over how it’s funding its investment in data centres
Results & Trading UpdatesJune 11, 2026Restructured PayPoint makes profit progressBuybacks continue to reduce the equity base
Results & Trading UpdatesJune 11, 2026NCC opts against a sale as cyber growth improvesCyber security annual cash profits are predicted to rise faster than revenues
Results & Trading UpdatesJune 11, 2026Norcros grows profits despite construction market weaknessRetrenchment and expansion are happening simultaneously at the bathroom fittings supplier
Results & Trading UpdatesJune 12, 2026RWS is helping build the AI models that threaten to replace itIts ‘TrainAI’ business is driving growth while its core service shrinks
Results & Trading UpdatesJune 11, 2026Restructured PayPoint makes profit progressBuybacks continue to reduce the equity base
Results & Trading UpdatesJune 11, 2026Norcros grows profits despite construction market weaknessRetrenchment and expansion are happening simultaneously at the bathroom fittings supplier
Results & Trading UpdatesJune 11, 2026Custodian’s steady growth continuesBolt-on acquisitions are helping, and more may follow
Results & Trading UpdatesJune 10, 2026Motorpoint outperforms rivals but challenges remainRetail vehicle sales rose by 7.8 per cent to a record 64,600 units
NewsJune 12, 2026SpaceX shares rise a quarter in record floatElon Musk’s rocket, internet and AI company raised $75bn in highest profile company float since tech boom began
Results & Trading UpdatesJune 12, 2026Oracle’s AI expansion is testing its balance sheet The company has come under scrutiny over how it’s funding its investment in data centres
Taking StockJune 12, 2026What the Berkshire deal tells us about the US property marketFirst major purchase by Warren Buffett’s successor points to a US sector ripe for consolidation
Ideas of the WeekJune 11, 2026This major miner is a bargain way to play gold and copperAn upcoming upheaval is fixing past mistakes and offers plenty of opportunities for ´óÏóÊÓÆµ
NewsJune 11, 2026AstraZeneca and Roche battle for a cancer breakthroughBillions of dollars are at stake as the pharma giants fight it out for the next winner in breast cancer treatment